<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>不可成药靶点 on AI内参</title>
    <link>https://www.neican.ai/tags/%E4%B8%8D%E5%8F%AF%E6%88%90%E8%8D%AF%E9%9D%B6%E7%82%B9/</link>
    <description>Recent content in 不可成药靶点 on AI内参</description>
    <generator>Hugo</generator>
    <language>zh-cn</language>
    <lastBuildDate>Thu, 04 Dec 2025 11:40:04 +0800</lastBuildDate>
    <atom:link href="https://www.neican.ai/tags/%E4%B8%8D%E5%8F%AF%E6%88%90%E8%8D%AF%E9%9D%B6%E7%82%B9/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>AI驱动药物设计的“AlphaFold时刻”：Chai-2如何原子级攻克“不可成药”靶点，重塑医药未来</title>
      <link>https://www.neican.ai/insights/aialphafoldchai-2-20251204114004763-0/</link>
      <pubDate>Thu, 04 Dec 2025 11:40:04 +0800</pubDate>
      <guid>https://www.neican.ai/insights/aialphafoldchai-2-20251204114004763-0/</guid>
      <description>Chai Discovery的Chai-2 AI模型正引领药物发现进入理性设计时代，其以原子级精度设计全长抗体的能力，成功攻克了GPCR和pMHC等“不可成药”靶点。这一突破不仅大幅提高了新药研发效率与成功率，更开启了万亿级的潜在市场，有望加速创新药物问世，深刻改变人类与疾病抗争的未来图景。</description>
    </item>
  </channel>
</rss>
